Literature DB >> 15016008

Nitric oxide synthase expression and enzymatic activity in multiple sclerosis.

H Broholm1, B Andersen, B Wanscher, J L Frederiksen, I Rubin, B Pakkenberg, H B W Larsson, M Lauritzen.   

Abstract

We used post-mortem magnetic resonance imaging (MRI) guidance to obtain paired biopsies from the brains of four patients with clinical definite multiple sclerosis (MS). Samples were analyzed for the immunoreactivity (IR) of the three nitric oxide (NO) synthase isoforms [inducible, neuronal and endothelial nitric oxide synthase (NOS)], and enzymatic NO synthase activity. MRI guided biopsies documented more active plaques than macroscopic examination, and histological examination revealed further lesions. Inducible NOS (iNOS) was the dominant IR isoform, while reactive astrocytes were the dominant iNOS expressing cells in active lesions. NOS IR expressing cells were widely distributed in plaques, in white and gray matter that appeared normal macroscopically, and on MR. Endothelial NOS (eNOS) was highly expressed in intraparenchymal vascular endothelial cells of MS patients. A control group matched for age and sex showed no such changes. Our data support the hypothesis that NO is a pathogenic factor in MS, and that NOS IR is strongly expressed in brain regions appearing normal by MRI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016008     DOI: 10.1111/j.1600-0404.2004.00207.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  15 in total

Review 1.  Nitric oxide and multiple sclerosis.

Authors:  Juan Manuel Encinas; Louis Manganas; Grigori Enikolopov
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

Review 2.  Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.

Authors:  Janos Paloczi; Zoltan V Varga; George Hasko; Pal Pacher
Journal:  Antioxid Redox Signal       Date:  2017-07-18       Impact factor: 8.401

3.  The importance of nitric oxide and arginase in the pathogenesis of acute neuroinflammation: are those contra players with the same direction?

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Radmila Pavlovic; Dusica Pavlovic
Journal:  Neurotox Res       Date:  2014-04-26       Impact factor: 3.911

Review 4.  White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.

Authors:  Melissa Cambron; Miguel D'Haeseleer; Guy Laureys; Ralph Clinckers; Jan Debruyne; Jacques De Keyser
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-04       Impact factor: 6.200

5.  A Peptide Targeting Inflammatory CNS Lesions in the EAE Rat Model of Multiple Sclerosis.

Authors:  Claudine Boiziau; Macha Nikolski; Elodie Mordelet; Justine Aussudre; Karina Vargas-Sanchez; Klaus G Petry
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

6.  Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells.

Authors:  Kevin Kemp; Elizabeth Gray; Elizabeth Mallam; Neil Scolding; Alastair Wilkins
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

Review 7.  NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: modeling a molecular mechanism.

Authors:  Bernardo Moreno-López; Carmen R Sunico; David González-Forero
Journal:  Mol Neurobiol       Date:  2010-12-29       Impact factor: 5.590

Review 8.  The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Roberta Brambilla
Journal:  Acta Neuropathol       Date:  2019-03-07       Impact factor: 17.088

9.  Serum nitric oxide concentrations in patients with multiple sclerosis and patients with epilepsy.

Authors:  Saida Ibragic; Emin Sofic; Enra Suljic; Nesina Avdagic; Azra Bajraktarevic; Ismet Tahirovic
Journal:  J Neural Transm (Vienna)       Date:  2011-07-21       Impact factor: 3.575

Review 10.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.